Protective Capacity of Statins during Pneumonia Is Dependent on Etiological Agent and Obesity
Open Access
- 15 February 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 8, 41
Abstract
Acute respiratory infections are a leading cause of death worldwide. Clinical data is conflicted regarding whether statins improve outcomes for pneumonia. Potential confounding factors including specific etiology of pneumonia as well as obesity could potentially mask protective benefit. Obesity is a risk factor for high cholesterol, the main target for statin therapy. We demonstrate that statin intervention conferred no protective benefit in the context of wild-type mice regardless of infectious agent. Statin intervention conferred either a protective benefit, during influenza infection, or detrimental effect, in the case of pneumococcal infection, in obese animals. These data suggest etiology of pneumonia in the context of obesity could be dramatically altered by the protective effects of statin therapy during bacterial and viral pneumonia.Keywords
This publication has 47 references indexed in Scilit:
- The Impact of Statin and Macrolide Use on Early Survival in Patients With Pneumococcal PneumoniaThe American Journal of the Medical Sciences, 2013
- Increased Pathogenicity of a Reassortant 2009 Pandemic H1N1 Influenza Virus Containing an H5N1 HemagglutininJournal of Virology, 2011
- Obese mice have increased morbidity and mortality compared to non-obese mice during infection with the 2009 pandemic H1N1 influenza virusInfluenza and Other Respiratory Viruses, 2011
- Effect of statin treatment on short term mortality after pneumonia episode: cohort studyBMJ, 2011
- Prevalence and Trends in Obesity Among US Adults, 1999-2008JAMA, 2010
- Statin use and risk of community acquired pneumonia in older people: population based case-control studyBMJ, 2009
- Prior Statin Use Is Associated with Improved Outcomes in Community-acquired PneumoniaThe American Journal of Medicine, 2008
- Pandemic Influenza: A Potential Role for Statins in Treatment and ProphylaxisClinical Infectious Diseases, 2006
- Leptin Regulates Functional Capacities of Polymorphonuclear NeutrophilsFree Radical Research, 2003
- Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action?Journal of Leukocyte Biology, 2001